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Misclassifications In Compustat:

IN-PROCESS R&D (IPRD) WRITE-OFF MISCLASSIFICATIONS
COMPUSTAT: IN
ECONOMETRIC EVALUATION
Lo lita Pa ll
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S tate Berks

Over th e period 1994-1999, for a sample of 57 firms, in-process research ami developm ent (IPRD) costs
write-off
5 were
reported in th e 10-Ks of approximately 12% of the obsen,ations. Th e IPRD amounts
ranged fi·om $230,000 to over $ 16 7 million. In 38% of these cases, Compustat overstated R&D expense by
including the IPRD write-off Comparative econom etric estimates obtained show larger parameter
stat
's R&D expense data was used. This suggests prior research on R&D tax
coefficients wh en th e Compu
credit eff ectiveness based on Compustat data may have been upwardly biased, overstating th e ULl: credit's
incentive effects. Policy implications and directions for future research are discussed.

JNTROD UCTION

Standard and Poor's Compustat databa se is frequent ly
used in accou ntin g, finan ce and eco nomi cs empiri cal
resea rch .
ot surpri sin gly. a fairl y ex tensive body of
litera ture in vesti ga tes thi s data source 's int e~rity across
va ri::~ble
anu yea rs. For ex amp le, Sa n Miguel ( 1977)
t usta 's reported 19 72 R& D ex pense
co mpares Comp
amounts to fir ms' I0-Ks, findin g a di screpancy in 30% o f
the sa mpl e o f firm s tes ted . Rosenberg and Hou glet ( 1974)
compa re stock pri ces in Co mpu stat to the Center for
Re ·ea rch in Sec urity Pri ces (CRSP) quotation s (du rin g
the 1960s) findin g no materi al e1Tors. Va sarh elyi and
Y:mg ( 1983 ) examine total assets, eum: nt li ab iliti es. net
sa les, net in come before ex traordin ary it ems. in ve ntories,
gross pl ant , anu 200
J ep rec
firms
i ::~t i o n lor
in 198 1. Th ey
0
finu error rates 0°o,
of .5°o, l
o, 3°·o, 4.5%, 6%, and
34.5°o, re spec ti ve ly. B e::~ n and G uerard ( 1989) co mpare
resea rch cx pend il ures reported in ( 'omp usta t to NSF :md
Cens us Burea u report s, fi ndin g th e Compustat amount s
tended to be hi gher due to difiC rences in R&D
defin iti ons. particularl y in I9n and 1979. Kinn ey and
Swa nso n ( 1993) exa mine the acc uracy of Co mpu stat's
dat::~ li elds over th e pen od 19/:;688. 19
findi ng
related
a total error frequency of 11 .65°o. Simi larl y, Man 7on
( 199-l)
t yincoi
find s Co mpusta
TL'C tl
reported Ne tOpe rat
g- 1lll
osses (NOLs) as 1.ero or mi ss in g in 3.8% of
the sam ple dunng th e yea rs 1982- 199 1, when a rev ie w o r
Kern
ise.anu
Morris
the firm ~' I 0-Ks sugges ted othetw
er
e cl'kel
co ns1ddataba
th se
choi ce (( ' om pu s t::~t v.
( 199-l)
Value I 111e) ha s on empi
zasricarc
il h.
rese
13 eu on da ta
from 1C) 77- J9l) I. th ey fi nd the choi ce databa
of se ''c
an
iTect the resu:t s ol' and inl'crenccs
ical
drawn from empir
.
rese::~ re h 111 "ays more than a n t1cip~1l e d by researchers"
(p .2S-l)
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Idea ll y, tax-re lated empirical research should be
per fonn ed with tax return data, since tax filin gs provide
th e mo st reli able infonnation on items such as corporate
tax li ab ili ties, NOLs, expenses, and tax cred its. However,
sin ce tax returns are confidential , most empirical research
on R&D ta x in centi ves on the fitm-l cve l has been based
on a variety of pu bli c data sources. (A ltshul er, 1989 is a
rare c x~.- e pt i on.) in the case of R&D tax credit studies,
da ta ou rccs used in clude McG raw-Hill Surveys (Co llins,
1983) ; Na ti onal Sc ience Foundation (NSF) reports
(Bai ley and Lawrence, 1992), I 0-K filin gs with the
Sec uri ti es and Exchange Commi ssion (SEC) (Paff, 2004
and 2005; McCchen,
ut
1993) , and Compustat (Swenson,
1992 ; Berger, 1993 ; Eisner et al, 1993 ; Hall , 1993; Hines,
1993; Bi llin gs and Fri ed, 1999 ; Billings et al. , 200 I).
T he literature eva luatin g the appropriateness and
potentia l biases associated with the use of Comp ustat or
other pub lic ly ava il ab le data in R&D tax credit related
resea rch has fo cused on the differen ces in de finiti ons
with respec t to what constitutes "research" or
"deve
" lop ment (Hall and Lon g, 1999), the effects of
::~ cco untin g rec lass ifi ca tions from non-R&D items to
R&D expense (Hall and Wosin ka, 1999) , and the
appropri ateness of usin g R&D ex pense as a proxy for
qua lifi ed resea rch expenditures for R& D ta x credit
purposes (llall an d van Reenen , 2000). Along a related
th eme, Bea n and Guerard ( 1989) compare R&D amounts
reported in Compu stat aga inst NSF data. Although their
results obtai ned with Compu stat data were not materi all y
dil'lc rent om
!'r
those obtain ed from NSF data , they did
observe signifi ca nt differences for certain industri es
across certain yea rs. " In ge neral it appea rs that firm s
over-report R&D ex penditure in Co mpu stat relati ve to
NSF/Ce nsus" (p.205). Simil arl y, I Ia II and Long ( 1999)
evalu
ate
the consistency and acc urac y of R&D data from
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two sources: firms ' 10-K filings with the Securities and
Exchange Commission (SEC) and the National Science
Foundation (NSF). They write:
Substantial effort appears to have gone into getti ng
the R&D numbers "right" by the profession al
accounting world, by which we mean following the
definitions and reporting requirements carefull y
and systematically, both within a sin gle company
and across companies ... We ha ve concluded,
therefore, that the best practical course is to use the
10-K data as a benchmark ... (p.27)
Interestingly, much less attention has been given to
the potential for bias and erroneous findings that may
result if the public data source suffe rs fro m di screpancies
or errors. Of particular note, Kern and Monis 's ( 1992 and
1994) effective tax rate studi es focused on examining and
reconciling the differences in empiri ca l results obtained
by testing the same theoretica l mode l with two different
databases, Compustat and Value-Line. This paper extends
that vein of research in two ways. First, since we are
unaware of any studies subsequent to San Miguel' s
comparison of Compustat v. 10-K rep011ing of 1972
R&D amounts, and given the fairly large number of R&D
tax credit studies utili zing Compustat data, a more recent
comparison of Compustat 's R&D expense to the amounts
reported in firms' 10-Ks durin g the period 1994-1999 is
provided. Second, this paper provides comparati ve
empirical results obtained by testing a model of R&D
investment sensitivi ty to tax pri ce changes with two
alternate data sources, 10-K filin gs and Compustat, for
the same sample of finn s. In contrast to MorTi s and Kem ,
this research focu ses on the differences between
Compustat data and the original source data, each fim1 ' s
10-K filings.
Of particular relevance is the possibility of encodin g
and classification of errors in Compustat by in cludin g
IPRD amounts in R&D ex pense . IPRD represents a
portion of the acquired firn1 's past expenditure for
research proj ects.
Because these amounts do not
represent current period expenditure for researc h activity
they are not pari of qualified resea rch expend iture for
R&D tax credit calculation purposes. Therefore, these
amounts should be exc luded from research and
development ex pense when R&D expense is used as a
proxy for qualifi ed resea rch expenditure in eva luatin g the
effectiveness of R&D tax cred it poli cy or testin g mode ls
ofresearch investm ent.
The accounting for and reportin g of R&D is go verned
by two Financial Accountin g Sta nd ard s Boa rd
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pronouncements, Statements of Fi nan cial Accountin g
Standards (SF AS) No. 2, Acco untin g fo r Resea rch and
Development Costs ( 1975) and No. 68 , Resea rch and
Development Arrangements ( 1985). Despite the re lative
consta ncy of accountin g policy, increases in merger and
acq ui siti on activity has comp li cated the accounting for a
closely related item, acquisitions of in-process research
and development (IPRD) . Thi s is beca use SFAS No. 2
" requires that R&D generally be expensed as in cun·ed
and that eac h year's tota l R&D be di sclosed in the
financial state ments . . . SFAS 2 cou ld lead to exaggerated
results in repmiin g the acq ui si tion of a compan y with in li
2003 , 46) . To illustrate the impact
process R&D" (Over
IPRD can have on a firm 's financial state ments,
Sta llworth and Di Gregori o (2005 ) note that Network
Assoc iates paid $131 million for CyberMedia in 1998.
T hey expensed 93 % of the purchase price as IPRD. Upon
completion of an SEC review, Network Associates
reversed $214 of the IPRD wri te-off.
Although publicized exa mples of large write-offs did
not occ ur until the mid-tolate-1990 s, corporations ha ve
been allowed to vvrite off IPRD sin ce the late 1970s. One
of the earli est and hi ghl y pub li c ized cases occ uned in
1990 when Lotus Development Corporation wrote off
$53 milli on or over 8 1% of the purchase cost of Samna
Corporation as in-process R&D. In 1993, C isco Systems
determined that 80 percent of its $ 120.5 milli on
acqui siti on of Lightstream Corp. could be ath·i butable to
purchased R&D (McGoldr ick, 1997). ''By the en d of
1996, the FASB was reported ly review ing its rules
governin g R&D write-offs. The SEC wa s sa id to be
in vestigating acq uirers' va lu ations o f purchased resea rch
and deve lopment" (Brow11ing, 1997; 30). As San Mi gue l
( 1977) notes :
Several factors may have contributed to the poor
quality of R&D data in th e 1972 Compustat
tapes . .. One was probabl y the ne wly impl emented
1O-K R&D di sc losure rul es.
T he new rul es
required th at different bits o f R&D information be
di sc losed in a vari ety of locations ... U nl ess these
fa cts were ca refull y ferreted fro m the 10-K 's
numerous sta tements, fo ohlotes, and sched ules,
errors 111 classi fyin g th e data were apt to re sult"
(p.639).
G ive n th e co mpl ex ity of IPRD acco untin g and the
reportin g of R&D-re lated inform ati on 111 mu ltipk
financia l state ment loca ti ons. suggests Co mpu stat ma y
ha ve some eJTors with res pect to a mounts reported as
R&D ex pense . lnd eed, ou r res ults show th at in the cases
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o f reported IPRD , Co mpusta t e n·ous
neo
ly
inc luded IPRD
in R&D and thereby overstated R&D expense, in 38% of
the observa ti o ns. A co mpari son of the econometr ic
res ul t sugges ts Co mpu stat da ta provide larger estimates
of fi rms' R&D tax price sens iti vity than those obta in ed
w ith data derived directly from firm ' 10-K s. T hese
find ings suggest th e tax pri ce e la ti c ity estima tes
obtained in prior R&D tax credit studi es using Co mpu stat
data (in c luding Swenson, 1992 ; B erger, 1993; E isner et
a !, 1993; J !a ll , 1993; Hines, 1993 ; Bi llin gs and F ri ed,
1999; Billings et a l. , 200 1 as noted prev io us ly) may have
been upward ly bi ased .
T he paper is organ ized as fol lows. Section 1:\vo
co mpares the 10-K and Co mp usta t data, providin g
summary sta ti sti cs, a nalys is of differences be tween R&D
expense re port ed across the data so urces, a nd potenti a l
exp bnations for the observed variations in reported
amo un ts. Section three pro vides a descript ion of the
empirica l mod e l, tax price computat ion methodology, and
the econo metric results from the I 0-K and Compu stat
data sets. T he pa per conc ludes w ith di sc ussion of the
impl icat ion s and limitati ons of these fi nd ings, and
sugge lions for improve d use of pub lic source data in
empirica l R&D po li cy researc h.

10-K Data vs. COMPUSTAT
Data Gathe ring and Reporting from Compustat
and I 0-Ks: Each yea r, publi cly owned co rporations arc
required to fi le an annua l repo rt ( 10-K) of fina nc ial and
operat ing information with th e SEC. The SEC requires
fim1s to submit thei r fi lings to th e EDGAR syste m.
EDGAR, the Electron ic Ga the1i ng A nalys is and Retrieva l
system, " perlom1s auto mated co ll ection , va lid ation ,
index ing, acceptance. and forwardin g of s ubmi s ion s by
com panies and o thers w ho a rc required by law to file
fon11s wit h the U .S. Sec uriti es and Exchange
Co mmi ss ion (SEC). Its primary purpose is to in crease the
effic iency and fa im ess of th e securiti es market for the
benefit of in\'Cstors. corporations, a nd the econo my by
accelerating the receipt, acce ptance, di sse mination , a nd
ana lys is oft1me sens iti ve corpo rate informat io n fi led with
the agency" (\\'W\\'.sec.gov/ed garla bo utedgar. htm).
Dur in g th e yea rs 1994- 1996, th e SEC phased in the
LDG R fi li ng requirement. For nearl y a ll th e fi rms in
this stud y. filin gs prior to 199G a re no t ava ilal) le in th e
I: DGAR syste m. l lowevc r, s ince firm s a re req uired to
report prior pe ri ods·
in fo rma ti o n for co mpa rati ve
purposes. the li lin gs tha t a re ava ilable us ua ll y in c lud e
financ ia l uata extendin g back to 1992, ass umin g th e firm
\\as in o peral!on .
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T he fi lin gs w ithin EDGAR are in pl ai n text fonnat
a nd HTML. T hi s makes for qui ck on line access, but does
no t a ll ow for the doW11loadin g anu sav ing of fil es in a
fo m1at that is convenient for ana lys is. H owever, given the
need fo r printab le vers io ns of thi s data by researchers
fi nanc ia l ana lysts, accounta nts, and investors, it is no\~
poss ible to acquire the SEC fi lin gs in Ri c h Text Format
(RTF) . EDG AR-online provides RTF vers ions of
EDGAR filin gs . The 10-Ks fo r a ll the fin11 s in the sample
were down loa ded fro m thi s prop1i etary service . The
filin gs down loaded from E DGAR-online are identical to
the fi lin gs w ith the SEC in a ll respects except that they
have been fo n11atted to RTF . To verify the acc uracy of
the fi li ngs as prov ided by EDG AR-online, one income
state me nt for every tenth firm in the sampl e was tested .
T he yea r o f the income statement wa s rotated in re verse
c hro no log ica l order to avo id bi as . There were no
discrepa nc ies bel:\veen the information in ED GAR and
the RTF version down loaded from E DGAR-online.
To veri fy that EDGAR-on lin e had not omitted
publi c ly ava ilab le infom1a tion from its data base, the
EDGAR r1a taba se wa s searc hed for a sa mpl e of finn s'
fi lin g and co mpared to the numbe r of filing s avail able
for that firm thro ugh E dgar-on line. Agai n, there were no
cases where EDGAR-on lin e suppli ed fewer fi lin gs than
what wa s pub lic ly ava il ab le fro m the SEC. Based on
th ese find in gs, we ass ume the data from the EDGARo nlin e fil es is equi va lent to the data with in the SEC ' s
E DGAR database.
So me firm s in the sa mp le were not publi cly OW11ed or
made the ir initia l pub li c offering (lPO) of stoc k during
th e stud y pe riod ( 1994-1999). In these cases, 10-K filin gs
ma y no t be ava il abl e. H owever, ano the r va luab le so urce
of fi nanc ia l state me nt data is the S-1 registTation , Section
II of a n S- 1 registTat ion , "Genera l form fo r registration
of sec uriti es under the Sec llliti es Act of 1933." In
paiii c ular, the " In format io n w ith Respect to the
Reg istrant
"
porti o n of th e S- 1 inc ludes the same fin anc ial
a nd o pe rati o na l data as a firm ' 10-K . There fore, in cases
whe re I 0-Ks were not ava il a bl e, the S- 1 registTatio n was
used as a n a lte rnate so urce. T he inc lusio n of S-1
rcg istTa ti on data is a n exa mpl e of a d iffere nce between
us in g firm s' fi lin gs with the SEC a nd us in g Compustat
fo r e mpiri ca l resea rc h. Co mpu stat data is limited to the
I 0-K as th e so urce of its fina nc ia l data . For exa mpl e, if a
firm we nt pub li c in 1997 , C'o mpu tat wo ul d not in c lude
pri o r peri ods' va lues, even if the da ta was reported in the
firm ' s S-1 reg istrati on . T hus, fin anc ia l results fi·om
pe ri ods be fo re th e firm 's stoc k were publi c ly tTaded are
no t ava il ab le in Compustat.
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Another important difference between Co mpustat data
and values obtained from SEC fi lin gs relates to
restatements of financial statement amo unts. F irms are
required to report multiple periods ' va lues in the fina ncia l
statements. For example, a fim1 ' s 1996 fi sca l year-end
statements will include income statements for at least
1995, but will often include 1994 as we ll. If a significant
event occurs during 1997, such as the ale of a busin ess
segment, or an acquisition of another fim1 , the 199 7 yearend statements wi ll segregate the materia l event and for
comparability purposes, restate the fi nancia l results of
prior periods . In thi s exampl e, 1996 and 1995 will be
restated as if the materia l event had occurred during those
periods. The data in Compu stat is intention
y
all adju sted
for greater comparabi li ty across periods. However, for
researchers usin g financial statement data as a proxy for
qualified research expenditure in R&D tax credit policy
evaluation, restated va lues are not appropriate . Therefore,
for purposes of thi s study, the data derived directly from
firms' 10-Ks were drawn from the earliest statement
avai lable first, working fo n vard to the more recent
filings. This ordering was necessary in order to obtain
amounts closer to the va lues the fim1 s likely used to
compute R&D tax credits.
To summari ze, Co mpustat' s and 10-K ' s repmied
research and develop ment expense amounts may di ffer
for one or more reasons. Compu stat may repo11 fewer
observations sin ce it is limited to 10-K fi lings as a data
source . The restatement of expen se fo r co mparative
fin ancial statement purposes, may affect ana lysis in time
series analysis or when year-speci fie fin ancia l statement
amounts are used as a proxy fo r a tax return item. Last,
accounting and reportin g complex ity for items such as
IPRD may result in cod in g and mi sc lass ification en ors in
Compustat.
Sample Selection and Desc riptive Statistics:
Compu stat was used to generate a prelimin ary sampl e of
fim1 s based on th e followin g screen ing criteri a:
•
•
•

ulati
Pop on Particulars:
SIC Codes : 2834, 2835, 2836,
7372, 7373
Fundamenta ls : R&D Ex pense > 0
Company Specifics : State: Ca liforn ia

T he sa mpl e size wa s prelimin ary becau se some- of the
firms selected by the screeni ng process co uld not be part
of the study for one or more reasons. First, only firn1 s
with all research activity confin ed to th e headquarterstate are in cluded in th e ana lys is. Limitin g the sa mp le to
single-state R&D perforn1ers res ulted in fairl y large
di ffere nces between the resea rch intensiti es of the

https://scholars.fhsu.edu/jbl/vol2/iss1/18

included and exc lud ed pharma ceutical . Note that testing
s in gle-state R&D perforn1ers exc lusivel y is not the same
as limiting th e samp le to finn s operating entirel y in one
state. Ind eed, over 47% of firm s in the sa mpl e had sale
and/or manu factu ring offices located in two or more
states. However, thi s selection criterion may ha ve
res ulted in relative ly young firm s bein g inc luded , and
older, more established fi m1s bei ng exc lud ed. Without
detai led infonnation regard in g the spendin g by location
of mu lti-site R&D perfonners, there is no way of
es timatin g R&D tax prices those fim1 s face.
Firms with in suffici ent or incomp lete data were
excluded. For example, some firm s may not have
public ly repmied financi al infonnation ava il able in pri or
year because they were pri vately held. P1i vate ly owned
fi m1s are not required to make pub li c the ir financial
state ments. ln other in stances, a finn may no t have been a
stand-al one en ti ty for the entire study period . Another
reason fo r a finn to be excluded from the study rel ated to
its yea r of fom1ation . In some cases, finn s in operation in
1994 may ha ve ceased to ex ist by the end of 1999. In
other cases, fim1 s operating in 1999 may not ha ve ex isted
in 1994 . Therefore, this tud y's outcomes pertain to the
resea rch
beha vior
of
ex istin g
and
survJvmg
ph armace uti ca l and so ftware firm s.
In addition to the research in ten sity differences,
exc lud ed firm s tended to be more profitab le. It is unclear
how thi s may have affected the results . If economi es of
sca le or scope ex ist in the ap pli ca ti on of R&D results, it
ma y be argued that larger fim1 s w ith multipl e-state
researc h and more pe1i ods in which net inco me was
re ported stand to ga in more from undertaking R&D and
from increased research tax credit rates than smaller fim1 s
w ith consistent losses . Thi s would mea n the results
obtai ned are sli ghtl y understated . Sin ce Compustat
cJrov id es compl ete data on pub licly owned corporations
ex clus ive ly, structural difference in R&D investment
bet,,·ecn pub lic and pri vate e ntities are not ca ptured in
these resul ts. Himme lberg and Petersen ( 1994) find that a
fa irl y large ponion of in vestment can be explain ed by
di fferences in internal fina nce. Thi s suggests publi cly
owned co mpani es ma y ha\'e an ad va ntage in finan cing
resea rch in vestment tha n their pr iva tely O\\ned
co untcq)ai1s . A ltho ugh R&D pending fo r public ly
owned sma ll firm s ma y be hi gher than for pri vatel y held
entiti es, it is not clea r wheth er a firm s· ownership statu s
affects in creme ntal c han ges in R&D im·estmc nt. Since
both grou ps s houl d be sim ilarl y mot ivated to reduce
co rporate in come tax li ab ili ty. it seems like ly that fim1 s in
both ca tegories would re -pond s imil arly. However,
beca use publi c i,ed own
co mpani es arc infl uenced by
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investor own ers hip and pub li c scrutiny, the investment
patterns observed may re fl ect greater volati li ty than

would be observed fo r pri vate ly owned firms (see
Bushee, 1998).

Table 1: Descriptive Statistics
Research & Develo pme nt Ex pense- 10-K & S- 1 Filings
Biotech
94-'96
ALL
So ftware
Mean
3 1,374
34 ,035
29,296
26,706
Std .Dev
.
132,845
68,500
88,8 14
10 1,7 10
Minimum
36
287
85
36
I ,009 ,880
47 1.1 00
7 19, 143
Max imum
1.009 ,880
17 1
N
342
150
192
Research & Development Expe nse- C ompu stat
ALL
So ftw are
Biotech
94-'96
Mea n
26 ,6 18
30,973
36,38 5
26 ,745
Std .Dev.
105,241
14 1,634
98, 100
63,905
Minimu m
36
36
287
36
Max imum
I ,009,880
I ,009,880
434.092
886, 197
n
342
150
192
17 1
I PRD Obse rvations- Derived from I 0-K F ilings
Biotech
ALL
Software
94-'96
Mean
20,8 18
17,495
25.248
19,343
Std.Dev
.
34, 169
35,00 1
33,495
36,8 36
Minimum
230
255
230
230
124,888
Max imu m
167,054
167,054
167,054
42
n
24
18
21
Note : A mo unts are in $ 1OOOs, except sa mp le s izes.

In summary, the firm s 111 thi s study can be
characte1i zed as sing le-sta te R& D perfom1ers, publi c ly
own ed pham1a ce utica ls and softwa re fim1s that have been
in operatio n s ince at least the ea rl y 1990s. It is un clear
whether any or all of the potenti al biases are present .
Add itio na l research is needed to ga in per pecti ve on
whether the res ults obtained are re presentati ve of all
firms in these industri es and across other states.
Tab le 1 re ports the descri pti ve stati sti cs of the net
sampl e in total and acros variou s sub-sampl es across
both so urces o f data . T he sample of 34 2 represents 6
annu al observations ( 1994-1999) for 57 fi rms (25
softwa re and 32 pham1ace utica ls/ biotech). A review of
the Compusta t an d I 0-K research and development
expense a mounts hows a fa ir amo un t of consistency
between the data so urces, pa rti cul arl y w ith respec t the
observed m inima and max ima . T hi s is true ac ross
industries as we ll as time peri ods. With respec t to th e
differences across the ph armace utica l and softwa re
industri es, the oftware indu stry has a hi gher mean
regard less of data source . ln additi on, the Compu stat
softwa re R&D is larger an d has greater dev iati on.
refl ec ti ng in pan the large r number of softwa re fim1 s that
reported TPRD wri te-o ffs.
Interes tin g ly, th e mea n R& D expense fro m the I 0-K 's
is hi gher than the Comp usta t mea n. However, the
standard devon
iati
fro m Comp ustat is greater. Thi s
suggests that Bea n and G uerard 's ( 19 89) findin gs from
the 1980s still ho lds: taken as a who le. Compusta t is
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97-'99
36,042
113,22 1
36
I ,009
,880
17 1
97-'99
35,329
112,049
83
I ,009,880
17 1
97-'99
22 ,292
32, 123
992
124 ,888
21

fair ly cons1::.tent to o ther data sources, but there are
in stances where material differences occur. The variation
appears to be attlibutab le to the software firms during the
yea rs 1994- 1996. This fi ndin g is consistent wi th software
firm s becomin g more cautiou s in recording and writing
down IPRD at the end of the decade in response to
increased SEC scrutiny (Dowdell and Press, 2002).
Eac h IPRD ob servation refl ects a year in whi ch the
firm wrote off some or all of its in-process research.
These observation s represent j ust over 12% of the
sa mpl e. Con s istent with the trend s reported in the
fin anc ial new , IPRD write-offs ca n involve large sums;
the sma ll est observati on was $230,000, the largest over
$ 167 million. A lso cons istent with a prior expectation is
the in crease in the mea n IPRD observed from the earli er
to the later period . The sli ghtl y larger number of software
firm IPRD observat ions a lso agrees with Dowdell &
Press (2002) who observed that over half of all reported
fin anc ial statement restatements occurred in the 73 7X
STC (Bus iness Serv ices - Computer Programming and
D ata Process in g ca tegory) and con curTentl y, large
numbe rs of fir-ms in the indu stTy made acqui sition s that
inc luded IPR.D .
Theoretical Model and Empirical Results
Theoretical Model of R&D Investment Based on
Tax Price Estimates : T he spec ifi cation and underlyin g
theoretica l mode l fo ll ow Paff (2004 and 2005 ) and Hines
( 199 1). Th e purpose of the model is to test fo r structura l
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shifts in the coefficients on the tax pri ces of R&D . The
variables are:

•
•

It- Refers to fim1 i in time pe ri od t

For bas ic researc h payments, ·'contract
ch," resear
above thres hold levels, the tax credit rates a re:

O,J..l - Exponents referring to R&D input and non -R&D
inputs respectivel y
~~_Parameter common to a ll fin11S in period t
\j/; _Fixed effect for fim1 i
U; 1 _Normall y di stri buted error tem1
S(Rc, RH, I) - Fim1 sa les are a function of in-hou se
and contract research as well as no n-R&D inputs
Rc _Contract research
RH _In-house resea rch
I -Non-R&D in vestments

•
•

Assuming, as did Hines, that firm s ' production follows a
Cobb-Douglas form:

S;,(Rc,,,
,IR;,) H;,

= (Rc;,)6 (RH;,)'1(J;,Y' ex p(¢, + '1/; + lt ;, )

1)

Separate specificatio ns for eac h form of R&D require
observations of each category of expendi ture. However,
only one variab le, R&D expen se, wa s observed fo r each
finn. The si ngle annua l observation wa s divided into
contract and in-house segme nts for the purpose of
estimatin g the ta x p1ices of each . Since th ere is onl y on e
observed independe nt variab le, the econometric testing
must be based on a s ingle equation:

The left side represents the natural log of the annu al
total research expend it-ure observed for each finn . The
specification ind icates that R&D ex pe nditure is a
functio n of time and fi m1 effects and the tax prices of
both fon11S of R&D .

•
In order to test firm s ' re earch investme nt
•
respons iveness to c hanges in R& D lax price c hanges
(PRe and PRH above), estimated ta x credits and tax p1i ces
for each firm in eac h period we re prepa red . The credit
rates used come direc tl y from state tax statutes. The
C aliforni a credit is patt em ed a fter the federal leg islati on,
with the purpose of rewardin g o nly th e R& D acti vity
undertaken w ith th e state. U nlike th e fede ral c redit, the
Ca li fo rni a credi t is pe rmane nt. For in -ho use R&D 1n
excess of a thresho ld amou nt, the tax credit rates are:
For tax years beg innin g pri or to 1I I /97: 8%
For tax yea rs beg innin g pri or to 1/ 1/99: II %

https://scholars.fhsu.edu/jbl/vol2/iss1/18

For tax years beg innin g pri or to 1/1 /97 : 12%
For tax yea rs beg innin g on or after 1/1 /97: 24%

As H a ll and Wosin ska ( 1999) di sc uss, "T he Ca li forn ia
law uses the federal de finiti o n o f the base le ve ls but with
the impo rtant feature tha t a lthough the R&D in te ns ity
used to determine the " Base
" A mo unt is the same numbe r
used in the federal ca lcul a ti on, the sa les figure by whi ch
it is mu ltipli ed is th e Ca li fo mi a share of tota l sales. Thi s
has the stran ge , but possib ly inte nded, e ffec t that a fi rm
with sa les throughout the United States bu t whi c h docs
a ll of its R&D in Ca liforni a can have a ra ther low ba se
le ve l of R&D spendin g rela ti ve to it s c urrent le vel, year
a fter yea r, even tho ugh it is not increasin g its R &D ..
The e ffect o f the pro visio n is to give firm s a stron g
in venti ve to loca te the ir R& D labora to ri es in C ali fornia ,
eve n if the rest of the fim1 is nationwide. It is likel y that
thi s is on e of the goa ls o f the legis
ion"
l at
(p .8).
Se ve ral o th er parame ters are also necessary fo r
estimatin g the tax pri ces. F irst, note that beca use by
des ign a ll firms in o ur sa mple do a ll their researc h
activiti es in th eir home state , we set the in -sta te R&D
fract io n w,= l .O as well as the U.S . R&D fract ion u ,= l .O
fo r all Finns. M oreover, we ass ume no tax credits for
inputs othe r than R&D . Anothe r parameter is the
ma rg in a l federa l corpo rate tax ra te, Tred· Thi s va ri es by
fim1 a nd by year accord in g to the somewhat com pl ex
statutory leve ls and the I OK o r S- 1 reports by the fi m1 o n
th eir leve l of be fo re-tax pro fi ts, as fo ll ows:

•
•

Tax Price Co mputations

•
•

For tax years beginning prior to I II /00 : 12%
Fo r tax years beg innin g on or a fter 1/1 /00 : 15%

•
•
•
•

I 5% if the year 's profit befo re ta xes > 0 & < $50,000
2 5% if profi t be fo re taxe :::=: $5 0 ,000 & < $75,000
34% if profi t be fo re taxes :::=: $7 5,0 00 & < £ 100
, 000
39% if profi t before taxes :::=: $ 100.000 & < $335, 000
34% if profit be fore ta xes ::::: $335,000 & < £ 10
milli o n
35 % if pro fi t before ta xes.::_
ion $ 10 m ill
& < $ 15
milli o n
38% if pro fit before ta xes > S 15 mi lli o n & <.
$ 18.333 333 milli on
35% oth erw ise.

F in ally, the federa l R&D creuit rates (Pc ami PH) we re
by sta tut e 0 .20 fo r a ll stud y peri ods, except 1995 anu
1996. Co ngress let the c red it lapse for the one year
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period between Ju ly 1995- June 1996. Effective ly, the
credit wa s zero for ha lf of eac h yea r. But our data is
an nua l. A lthough not idea l beca use firm s cou ld have
fro nt or back loaded R&D expenditures, we used an
average 0. 10 federal credit rate for eac h of those fu ll
yea rs.
Fo r a typ ica l exa mpl e, one so ftware firm in the samp le
faced the fo ll owin g characteristics re lative to contract
re ea rc h in 1999:
•
•
•
•
•
•
•
•

credit, the reductive effect of both the firm's 35 percent
federa l corporate tax bracket and the 8.84 percent
Cali fom ia corporate tax rate, and accounts for a bit of out
of state sales apportionment.
Note the effect of the change in California's tax laws.
In 1996 and prior years, the state-level credit rate for
contract research was only 12 percent, while the
corporate tax rate was 9 .3 percent. If the rates had not
changed, a fim1 with otherwise similar characteristics
wou ld have faced an effective price P'c = $0.3893,
roughl y 20 percent hi gher.

Sta te R&D credit rate for contract research : Yc = 0.24
Federal R&D credit rate for contract research: Pc =
0.20
Federa l corporate tax bracket: Lfcd = 0.35
State corporate tax: Lin = 0.0884
in -sta te sa les apportionment fraction: a = 0.9575
In -state R&D fraction : We = 1.0 [True for a ll firms in
sample]
US R&D fraction: u c = I. O
Average out of s tat e ta x: Lout= 0.075

E mpirica l Results
Tabl e 2 provides the pharmaceutical and software
results fo r the entire pe1i od obtained from Compustat and
firm s ' I 0-Ks. The Contract (LNPRc) and in-Hou se
(LNPR11 ) variab les are the natural logs of the estimated
tax pri ces of bas ic research and in-house R&D
respective ly. A lthough there are many factors that affect
a firm 's R&D expenditure choice, the regression suggests
a fair amo unt of the va riation in research expenditure for
the period 1994 throu gh 1999 can be explai ned by the tax
prices of R&D . F irms average sa les and hi storical
resea rch inten sity (R&D to sa les ratio) were the on ly
stati sti ca ll y s ignifi ca nt fi xed effects. Other potenti al
ri ght-hand-side variab les were also tested , but were not
found to have any s ignificant explanatory power. These
variab les in c luded the net inco me/ loss position of the
fi rm each year, SIC-spec i fi e dummy va riables, a year-end
dummy segrega ti ng the finn s with a D ece mber 3 1
reportin g date from finns with a fi scal yea r-end d ate, an
initi a l publi c offering (IPO) va riabl e and the age of the
firm as o f 1994.

So the e ffec ti ve tax price for contract researc h (P'c)
for thi s fim1 in 1999 is:

•
Pelle
•

and Teachin g

P'c = [a ( 1 - L,n)
+ (I

-a)( ! -L 0 ,n) - YcWc( l -Lin)]( 1 - Lfed)
P'c = [0.9575( 1 - 0.0 884) + ( 1 - 0.9575)( I - 0.075) 0.24(1)(1 -0.0884) - 0 .20(
=1)]( 1 - 0 . 35)
= $0 .3207

ln other wo rd s, th e added cos t to the fim1 of one more
dollar of R&D spendin g for thi s firm , after ta x cred its is
onl y 32 ce nts . Thi s renects th e combined 24 percent
contract R&D cred it in Ca lifomia, 20 percent Federa l

Table 2: Co mparativ e Regression Results
So ftware

l'ha rmacc u ti ca ls
Co mpu trll
10-K s10-K

Co mpus

wt

VAHIABLE
-I. 793 2***
- 1.8095
6
- 1. -191 **
-5 . 7840**
(.5344)
(. 1495)
(.9529)
(2 .6739)
L I'R II
-12 .025-1*** -27.3879* * -0 .9758
25 . 7429***
(4.4649)
( 12.89 0) (3.30
) 1-1
(7 .6263)
I 1\
3 1· NS
* I· 0 . -0 .006 1*
00
0.6241***
0.598 1* **
(.0028)
( 0040)
(.0760)
(. 1476)
I NSi\ 11-.S 0 .70 003
12***
11 *** 0 .0689***
0 .5329***
(0115)
(026~)
(.0347)
(.042 5 )
N
I 92
I 92
I 50 R' 0 .83 10 0 I2620
50
0 .0 I
Jt!O
5650
,\dj·
Note: '**, **,a nd * represent "gntlic"nce to .00 I . .05 and . I0. respec ti ve ly.
Whttc ';, "dJu, tcd s ta ndard ctTOrs
c s ar
ho wn
in parentheses.
I NI'RC

.

C hanges in the s ize of th e coe fficients or significance
of the tax price variab les pro vide ev idence of stru ctura l
shifts betvvecn th e time per iod s . The most co mpe llin g

Published by FHSU Scholars Repository, 2006

ev iden ce of the e ffec t state- leve l tax credit changes on
resea rch ex penditure is suggested by di fferences between
the 1994- 1996 and 1997 -1 999 re necting finn s' sensiti vity

164

7

Journal
(2005-2012), Vol. 2 [2006], No. 1, Art. 18
Paff of Business & Leadership: Research, Practice, and Teaching
Journa l of 13u; mess and Leadership Researc h, Prac ucc . and Teachin g
to the reduced tax prices of R&D th at res ulted from
California ' s increases in research tax credit rates that took
effect in 1997. The results for the comb in ed 1994 -19 99
periods serve as a benchmark from whi ch the robustness
of the model in explaining resea rch expendi ture may be
evaluated. With respect to the model' s abi lity to ex pl ain
R&D investment, there are dramatic differences in th e
coefficients across industri es. Note the d ifferences in
coefficients obtained from the two sources of data.
The pharmaceuticals show consistentl y nega ti ve tax
price coefficients, re fl ecting the in verse relation ship
between firm s' investment in R&D and the tax pri ce
faced . The in-house R&D (LNPRH) variable shows
consistently more nega ti ve coefficients, hi ghlightin g

these firm s' greater sensiti vity to cha nges in the ta x price
of in-hou se re earch over ba sic resea rch. Thi s outcome
ma y seem so mewhat surpri sing. However, the I 0-K
di sc losures of many of the pharmaceuti ca ls in cluded
subcontractin g relation ship s with large r, more mature
pharmaceu ti ca ls. Fim1s hired to perfonn research for
others are probabl y less like ly to subcontTact research to
co ll eges and uni versities. If the fim1s are not inves ting in
basic resea rch , the tax pri ce of research should not have
s ignificant exp lanatory power. Hen ce, th e lower basic
resea rch (LNPRC) coefficient may be more a refl ection
of the characteristi cs of the ph am1aceutica l firm s in the
sample than the effect the tax price of contract R&D ha
of finn s' research choice.

Table 3: Comparative Results by Time Period- Pharmaceuticals
199~-1 996

Pha rmace uti ca ls
10-K
Compusuu
LNP RC
2 8072
-2 0500
(34844)
(7.9349)
LNPRH
-148 .8600*** - 166.3730***
(28 . 7007)
6.J 6168
INT ENSE
-0 .002-l
(.02-l
I)
(.0032)
0 .0075
(.0035)
(.006 1)
0 .0553***
0 .0837 **
(.0149)
(.0393)
N
96
96
1
Adj- R
OJ960
0 .1260
***, **.and * represen t s1gndi cancc
White' s adjusted s tandard en·ors are m
sh0\\11

VARIABLE

LNSALES

No te·

The software in -house results are start li ng. Un li ke th e
pharmaceutical s, the R&D in tensity and sales vari ables
are consistentl y sign ifi cant and larger for the software
firm s. This most like ly re fl ects the inherent re search
investment differences between the two indu stri es. Many
of the pharmaceutical s' 10-Ks indi cated they are
categorized as development stage compan ies; firm s that
have never had prod uct sa les . The software fim1
typically had multiple produ cts and maintenan ce conb·act

1997-1999
Pharmaceuticals
10-K
Co mpustnt
- 1 7642***
-1.5086**
(.695-l
)
(.7 602)
-30 .8675***
-3 1. 7852**
( 12.4532)
(16.06 18)
-0 .0072**
-0 0012*
0 .0362**
0 .0-109*
(.0177)
(02-11)
96
96
0.2430
0.28~0
to .00 I, .05 and . I 0, respecuvel)
parentheses.

revenues. Thus, research intensity mea urcd in tenns o f a
ra tio to sa les and the logar ithm of ave ra ge sales have a
greater relation ship to so ftwa re firm s' R&D ex penditure
choi ce than the pharmaceuti ca ls in thi s stud y. Of grea ter
interes t is th e Compusra t sign ifi cance and pos itive sign
on the tax pri ce of in-hou se researc h. A positi ve sign
seems t indi cate a pos iti ve relation ship betwee n inhou se R&D's tax price and fim1 investm ent . Thi s see ms
unlikely .

Table 4: Co mparati ve Results by Time Period- Software
1 99~- 1 996

1997- 1999
So ftware
Soft"arr
10-A'
Compll.\fnl786
10-J..:
Compustar
VA RIEA BL
8.13X3**,..
.j
-l "** 81383*** -l 786-l***
I NPRC
(I I J-161
( 1 053 I)
(I 13-16)
(I 053 I)
9 9985*
-0 7.1T
-0.7'>77
9 'l9R5*
I NPRJI
38.367
(9 -1517 )
I:
.9
(5 6059)
517) (9. -1
(5 6059)
38 3679'**
9*'
9.5698
INT F NS
.5 (191-i
( 12 2005)f\LI::S
(8 3013) ( 12 2005) (8301 J)
061~X***
0 6~~5*** 0.618~*;#. () 62~5***
I NS
( 1073)
( 2-135)
35 ) (.2-1
( 107.1)
75
75
75
75
N
()-J<)
() 769
0 -1
9
0 769
AdJ- R'
I 0. rc>pccll\
Note · ***.*'.
1nd •
represent Slgllllicance to .001. 05
\Inand
m parcn
thcsc> . ely
Wh1t e's
>hO
adju, tcd olandard en·or>
arc
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In order to better understand the unex pected s ign of
the Compu s tat software firm s' in-hou se research
coe ffi c ient, a nal ys is ac ross the two time periods needed.
Tab les 3 and 4 above re port the comparative data source
res ults aero eac h time period for the pharmace uti ca l and
software firm s, respec tivel y . The Co mpu stat- and 10-Kba sed results for the ph a nnaceutica ls a re quite s imil ar.
The primary diffe rence is from differences in the level of
the coeffici e nts. Th e tax ptices, if s ignificant, are
con s istentl y negative for the res ults ba sed o n both data
ources. However, the coeffi c ients fTom the Compustat
sa mple tend to be la rger. T hi s is probabl y clue to
Co mpustat 's inclus ion of in-process R&D (IPRD)
amo rti zation as part o f R&D expense.
Larger expe nse values u ed in th e a na lys is wo uld tend
to bi as the e ffec t of an R&D c redit upward. A likel y
explanat io n may reflect the limited amo unt of resources
devoted by these fim1 s towa rd ba s ic research in vestment.
Another expl ana ti on m::ty be related to the inherent
d tfficu lti es in appro pria te ly labe lin g so ftw a re R&D
through the th rcc-s t::tgc process required by th e PASB.
The in vestment c ho ices of researc h man agers may
ultimate ly have litt le corre lati on to the a mounts repotied
in the finan cia l statements as resea rc h and deve lopme nt
expense . More troub lin g fro m a n e mpiri ca l se nse is the
po ibility th a t th ese a ·co unting va lu es may a lso bear
littl e rese mbl ance to the :1mo unts th e fim1s report as
qua lifi ed research expendi ture w hen app ly ing fo r R&D
ta x credit . Thus, th e usc of publi c dat::t for resea rc h on
th e softwa re industry·s scn s tti vity to c han ges in researc h
tax pri ces may be inappropriate.
F urt he r analys is of th e I 0-K a nd Co mpusta t res ults
impot1ant
differe nces.
There are
revea Is o the r
inco nsisten c ies in the parameter shift s from th e ea rl y to
ren ccs in the
later period , differences 111 s ig ns, and di f"!C
leve ls of the codlicient s. "I hesc result s ha ve se vera l
possible exp lanations. It may be that th e model cannot
detect the re la tion ship be tween tax price a nd R& D c hoi ce
for so ftware firm s beca use th e tax pn ces were not that
impo rtant to these firm s in the 1990s . "J ust to stay
com pe titi ve, software deve lope hrs h a\'\~ ::td to in ves t
heav ily in R&D a t a pace th a t eve n e.\ eeed s their ove ra ll
business g row
the mpan
s
.. .!\ pos it ive aspec t o f the rap id
growth ha s bee n the lackm of co nce
over any loss in
gove rn ment re sea rc h fundin g due to fede ra l tbudge
c ut
s"
(Researc h and J)e,·eelo
ntpm
.
1996: 4 A) . Thu s, in du stryspecific factors such as the do t-co m phenomenon ma y
have been m orel influ cnll::t 111 spurrin g the R& D dec is ion s
of softwa
nre firm s th
:J c han ges in R&D wx c redit po li cy.
/\ lterna tcly , de te rmintn g R& D ex pense prec ise ly is
more com ple x fo r software firm s, thu s introducin g noi se
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in the estimation. In particular, SFAS No. 86 Accounting
for the Costs of Computer Software to be Sold, Leased or
Othenvi se Marketed ( 1985) req uires fillll s to follow a
tlu·ee stage categori zation of research costs re lated to
software R&D. For exa mple, software R&D costs
incun·ed prior to product feasibility being establi shed
should be expen sed. During software producti on , all
re levant co ts s hould be cap itali zed (reported as an asset
o n the balance sheet) . O nce the product is available to
c usto mers, amortization of the capitalized costs shou ld
begin. Detetmining w hen a product has progressed from
stage o ne, where costs are expensed, to stage two where
costs are capita li zed is difficult and subj ective. Thus, the
amo unts reported as research and development expen se
in finn s' I 0-Ks ma y not necessarily reflect the actual
researc h ex penditure of firm s . Additionally, Compu stat
may ina ccurately code o r c lassify the capita li zed and
ex pensed portion s of R&D . Further compli cating the
issue a rc th e difference in definition s utili zed by the [RS
and Gene ra ll y Accepted Acco untin g Principles (GAAP).
Qua lifi ed resea rch ex pe nditure, as spec ified by lntemal
Reve nue C ode l74 , is not de fined the same as research
expe nse in S AS No. 2. For exampl e, SFAS No. 2
excludes legal fees re lated to patent appli cations, but IRC
174 in c ludes the m (O li ver, 2003) .
The in cons iste nc ies in the so ftware resu lts are
some what troublin g beca use we cannot c learl y detennine
if the in cons iste ncies arc due to Co mpustat data gathering
and re po rtin g iss ues or troub les assoc iated w ith u ing
fin ancial statement va lu es 1n general to estimate
confident ia l ta x return inform ation , or more generall y to
diffi c ulti es
111
accou ntin g
for
software
R&D.
Additional ly, anal ys is based on s ubseq ue nt time period s
wo uld hi g h lig ht whet he r subsequent changes tn
accounting and reportin g req uireme nts regarding mergers
and acq ui s ition s, inc luding treatment of intangibl e assets
and in-process research s how persi ste nt differences
betwee n Co mpu stat and I 0-K data .

CONCLUSIO N
D es pit e th e un certainties with respect to the software
res ult s. the rq
,rrcss io n
result are con sistent wit h pri or
fed·ecra
l l-Je,
studi es that show R&D tax credit e ffec ts
va ry roJc ss indu stri es (Man s fie ld 1986; Berge r 1993;
Mamun eas a nd Nadi ri 1996). There arc dramatic
di ffcrc nccs in th e R&D spe nding, sa les and tax price
coe ffi c ie nt estima tes obt:Jincd for th e softwa re and
ph armaceu ti ca l firm s in thi s stud y. Of particu lar note arc
th e impli ca ti on s these results have for other studies b:1sed
on Compus tat data. Because Compu stat frequent ly
in c lud ed th e amorti za ti o n of IPRD in th e va lue of R&D
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reported, R&D expense was often overstated. This means
the tax price sensitivi ty estimates obtained fro m
Compustat data may be bia sed up ward. The ta x pri ce
coefficients were consistently hi gher wh en the Co mpu stat
data was used than when the 10-K va lues were tested. For
policymakers, this means that bigger c hanges in R&D tax
credit rates may be needed for state po l icy setters to
achieve a target amount of R&D expenditure change.
Although there may be sampl e se lectio n effec ts
associated with analys is limited to sin gle-state R&D
producing firms, we cannot predi ct with ce rta in ty the
direction of those effects. Some may suggest that a stud y
based on single-state, small R&D inten s ive firms ma y
overstate the C alifornia ' s resea rc h ta x cred it policy
effectiveness . However, larger, more profitab le firm s
with multiple-state R&D m ay stand to benefit eve n more
from a state-level incenti ve than the firm s included in th is
paper. If the location of researc h act ivity is a stTategic
decision, then fim1s with multipl e-state operation s may
react by reallocating the sa me aggregate spendin g to
those location s with the lowest tax pri ce in o rder to
benefit from the increased credit rate. G iven the
incremental nature of the credit. in order for firm s to
benefit from higher rates of credit, their research inte nsity
must increase over time. Thus , for multi-state R&D
performers, the appearan ce of inc reased R& D intensity
for state credit calcu lation purposes can be achieved by
merely shiftin g the location of current leve ls of acti vity .
In contrast, the s in gle-state R &D perfom1in g firm s ca n
only continue to rece ive the cred it by ac tuall y in creasin g
research spendin g re lative to the ir sa les. Based on the
available data , there is no way of kno w in g w hi c h group
of firms respond s to a greater degree to c ha nges in statelevel poli cy.
These findin gs are impo rtant to state- and Ce derallevel R&D poli cymakers for severa l rea so ns. F irst, po li cy
makers should con sider the d iffere nces across indu stri es
when crafting researc h poli cy o n the federal o r sta te
leve ls. The software and pharmace utical firm s ex hibited
vari ation in R&D in vestmen t behavior, and we re
divergent in the ir sensitivity to state- leve l R& D tax
cred its . A common po li cy con cem fo c uses on the
poss ibility the public sector is fi nan c in g researc h activ ity
that would have occuned even in the absence of the
incentive. In thi s rega rd, the pos itive so ftware tax pri ce
coeffici ent is parti c ul arl y tToub lin g. Th e noti o n o r
software firn1 s ex hibi tin g a pos iti ve re lati o nship between
the tax pri ce of R&D and research in,·es tme nt suggests
these firm s may have been rewa rded fo r R&D th at wou ld
ha ve been undertaken e ve n i r th e c redit \\'ere not
stal eI le\C
available . At best, the incen ti ve e ffec ts

or
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research tax credits are modest with the results dependent
on th e data source used.
Th is pa per pro vid es further ev ide nce of the limitatio ns
and care that mu st be emp loyed in eva lu ating research
results obta in ed with Compustat 's R&D data. Future
researc h should con sider alte m ate time periods and firm s
in other indu stri es in order to shed li ght o n the robustness
o[ the results herein . Idea ll y, eva lu ation o f R&D ta x
credit po li cy should be perforn1ed us in g ta x return data.
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